As of 2025-11-01, the Intrinsic Value of Vor Biopharma Inc (VOR) is -1,216.69 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 24.11 USD, the upside of Vor Biopharma Inc is -5,146.39%.
Based on its market price of 24.11 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 5,146.39%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1,216.69 - -1,216.69 | -1,216.69 | -5,146.39% |
| P/E | (3,635.47) - (3,635.47) | (3,577.06) | -14936.4% |
| DDM - Stable | (2,406.17) - (8,317.11) | (5,361.64) | -22338.2% |
| DDM - Multi | (3.15) - (8.16) | (4.50) | -118.7% |
| Market Cap (mil) | 164.91 |
| Beta | 6.08 |
| Outstanding shares (mil) | 6.84 |
| Enterprise Value (mil) | -25.66 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.86% |
| Cost of Debt | 5.00% |
| WACC | 6.26% |